Press Room

2023 CPhI North America

Start
Tuesday, April 25, 2023 - 00:00
End
Thursday, April 27, 2023 - 00:00
Location: Philadelphia, USA
Booth Number: 723
The Leader in Spray Drying | Hovione

Visit Hovione at CPhI North America - Booth #723 - and discover more about the latest technologies and innovations in drug development.

 

Continuous Tableting for your drug product. The future is continuous | Hovione

The Future is Continuous

Meet our experts and find out if Continuous Tableting is right for your product.

ASD-HIPROS | Hovione

ASD-HIPROS

Learn how this platform can identify the best performing and stable formulations for your drug.

Hovione, The Leader in Spray Drying | Hovione

The Leader in Spray Drying

Know how to improve your drug solubility with the best scale-up science.

Click here and Get in touch today | Hovione

Schedule a meeting today

We look forward to seeing you at CPhI North America and support your project.

 

 

Let’s discuss your project together.

schedule a meeting

 

 

 

Schedule a meeting with our experts.

 

Find more about CPhI North America.

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025